Showing 531-540 of 639 results for "".
- AestheticsWire Exclusive: Embracing Diversity in Aestheticshttps://modernaesthetics.com/news/embracing-diversity-in-aesthetics/2473528/There’s no such thing as a one-size-fits-all approach to rejuvenation as people across genders, ethnicities, and age groups often have different concerns and aesthetic goals. This is the main takeaway from a new study that sought to better understand facial and body aesthetic conc
- Hair Relaxers Linked to Uterine Cancer in Black Womenhttps://modernaesthetics.com/news/hair-relaxers-linked-to-uterine-cancer-in-black-women/2473506/Long-term use of chemical hair relaxers by postmenopausal Black women may increase risk of uterine cancer, according to a new study by researchers at Boston University’s Black Women’s Health Study (BWHS). These products contain potentially harmful ingredients, including chem
- Meet the Beauty Health Company’s New CFO: Michael Monahanhttps://modernaesthetics.com/news/meet-the-beauty-health-companys-new-ceo-michael-monahan/2473471/Michael Monahan is The Beauty Health Company’s new Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition. "Michael
- New Skin-Responsive FUE Technique Improves Hair Restoration Results Among Individuals of African Descent,https://modernaesthetics.com/news/new-skin-responsive-fue-technique-improves-hair-restoration-results-among-individuals-of-african-descent/2473468/A new follicular unit excision (FUE) device may improve hair restoration results among individuals of African descent, according to a study in Dermatologic
- News You Can Use: RVL Rolls Out New Prescription E-commerce Platform, ELEVATEhttps://modernaesthetics.com/news/news-you-can-use-rvl-rolls-out-new-prescription-e-commerce-platform-elevate/2473442/RVL Pharmaceuticals is launching a prescription e-commerce platform. ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional&nb
- Eyebrow Thickness? It’s in Your Geneshttps://modernaesthetics.com/news/eyebrow-thickness-its-in-your-genes/2473425/The first gene mapping study on eyebrow thickness in Europeans discovered three previously unreported genetic loci, suggesting that eyebrow appearance has partly the same and partly different underlying genes in people from different parts of the world. The study, conducted by the Inter
- FDA Approves Galderma's Restylane Eyelighthttps://modernaesthetics.com/news/fda-approves-galdermas-restylane-eyelight/2473423/The U.S. Food and Drug Administration (FDA) approved Restylane Eyelight, a hyaluronic acid (HA) dermal filler for the correction of undereye hollowing, in adults over the age of 21. Restylane Eyelight is formulated with NASHA Technology, which has a firm gel te
- Sentient Introduces Tixel in the UShttps://modernaesthetics.com/news/sentient-introduces-tixel-in-the-us/2473416/Sentient is rolling out Sentient Tixel in the US. Sentient Tixel uses thermal-mechanical action technology to resurface skin. Tixel technology uniquely combines heat with the forward motion of a medical-grade titanium tip without the use of lasers, radiation, ultrasound, or needles.
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).